Cargando…

NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice

Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition, affecting up to 25% of the population worldwide. NAFLD has been linked to several conditions, including hepatic inflammation, fibrosis, and hepatocellular carcinoma (HCC), however the role of NAFLD in cholangitis and the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Shin, Hikiba, Yohko, Fujiwara, Hiroaki, Ikenoue, Tsuneo, Sue, Soichiro, Sugimori, Makoto, Matsubayashi, Mao, Kaneko, Hiroaki, Irie, Kuniyasu, Sasaki, Tomohiko, Chuma, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019203/
https://www.ncbi.nlm.nih.gov/pubmed/33506599
http://dx.doi.org/10.1111/cas.14828
_version_ 1783674331847458816
author Maeda, Shin
Hikiba, Yohko
Fujiwara, Hiroaki
Ikenoue, Tsuneo
Sue, Soichiro
Sugimori, Makoto
Matsubayashi, Mao
Kaneko, Hiroaki
Irie, Kuniyasu
Sasaki, Tomohiko
Chuma, Makoto
author_facet Maeda, Shin
Hikiba, Yohko
Fujiwara, Hiroaki
Ikenoue, Tsuneo
Sue, Soichiro
Sugimori, Makoto
Matsubayashi, Mao
Kaneko, Hiroaki
Irie, Kuniyasu
Sasaki, Tomohiko
Chuma, Makoto
author_sort Maeda, Shin
collection PubMed
description Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition, affecting up to 25% of the population worldwide. NAFLD has been linked to several conditions, including hepatic inflammation, fibrosis, and hepatocellular carcinoma (HCC), however the role of NAFLD in cholangitis and the development of cholangiocellular carcinoma (CCC) remains poorly understood. This study investigated whether a high‐fat diet (HFD) promotes cholangitis and the development of CCC in mice. We used liver‐specific E‐cadherin gene (CDH1) knockout mice, CDH1(∆Liv), which develop spontaneous inflammation in the portal areas along with periductal onion skin‐like fibrosis, similar to that of primary sclerosing cholangitis (PSC). An HFD or normal diet (ND) was fed to CDH1(∆Liv) mice for 7 mo. In addition, CDH1(∆Liv) mice were crossed with LSL‐Kras(G12D) mice, fed an HFD, and assessed in terms of liver tumor development. The extent of cholangitis and number of bile ductules significantly increased in mice fed an HFD compared with ND‐administered CDH1(∆Liv) mice. The numbers of Sox9 and CD44‐positive stem cell‐like cells were significantly increased in HFD mice. LSL‐Kras(G12D) /CDH1(∆Liv) HFD mice exhibited increased aggressiveness along with the development of numerous HCC and CCC, whereas LSL‐Kras(G12D)/CDH1(∆Liv) ND mice showed several macroscopic tumors with both HCC and CCC components. In conclusion, NAFLD exacerbates cholangitis and promotes the development of both HCC and CCC in mice.
format Online
Article
Text
id pubmed-8019203
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80192032021-04-08 NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice Maeda, Shin Hikiba, Yohko Fujiwara, Hiroaki Ikenoue, Tsuneo Sue, Soichiro Sugimori, Makoto Matsubayashi, Mao Kaneko, Hiroaki Irie, Kuniyasu Sasaki, Tomohiko Chuma, Makoto Cancer Sci Original Articles Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition, affecting up to 25% of the population worldwide. NAFLD has been linked to several conditions, including hepatic inflammation, fibrosis, and hepatocellular carcinoma (HCC), however the role of NAFLD in cholangitis and the development of cholangiocellular carcinoma (CCC) remains poorly understood. This study investigated whether a high‐fat diet (HFD) promotes cholangitis and the development of CCC in mice. We used liver‐specific E‐cadherin gene (CDH1) knockout mice, CDH1(∆Liv), which develop spontaneous inflammation in the portal areas along with periductal onion skin‐like fibrosis, similar to that of primary sclerosing cholangitis (PSC). An HFD or normal diet (ND) was fed to CDH1(∆Liv) mice for 7 mo. In addition, CDH1(∆Liv) mice were crossed with LSL‐Kras(G12D) mice, fed an HFD, and assessed in terms of liver tumor development. The extent of cholangitis and number of bile ductules significantly increased in mice fed an HFD compared with ND‐administered CDH1(∆Liv) mice. The numbers of Sox9 and CD44‐positive stem cell‐like cells were significantly increased in HFD mice. LSL‐Kras(G12D) /CDH1(∆Liv) HFD mice exhibited increased aggressiveness along with the development of numerous HCC and CCC, whereas LSL‐Kras(G12D)/CDH1(∆Liv) ND mice showed several macroscopic tumors with both HCC and CCC components. In conclusion, NAFLD exacerbates cholangitis and promotes the development of both HCC and CCC in mice. John Wiley and Sons Inc. 2021-02-14 2021-04 /pmc/articles/PMC8019203/ /pubmed/33506599 http://dx.doi.org/10.1111/cas.14828 Text en © 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Maeda, Shin
Hikiba, Yohko
Fujiwara, Hiroaki
Ikenoue, Tsuneo
Sue, Soichiro
Sugimori, Makoto
Matsubayashi, Mao
Kaneko, Hiroaki
Irie, Kuniyasu
Sasaki, Tomohiko
Chuma, Makoto
NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
title NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
title_full NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
title_fullStr NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
title_full_unstemmed NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
title_short NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
title_sort nafld exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019203/
https://www.ncbi.nlm.nih.gov/pubmed/33506599
http://dx.doi.org/10.1111/cas.14828
work_keys_str_mv AT maedashin nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT hikibayohko nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT fujiwarahiroaki nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT ikenouetsuneo nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT suesoichiro nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT sugimorimakoto nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT matsubayashimao nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT kanekohiroaki nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT iriekuniyasu nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT sasakitomohiko nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice
AT chumamakoto nafldexacerbatescholangitisandpromotescholangiocellularcarcinomainmice